# Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation

> **NCT01196923** · PHASE4 · COMPLETED · sponsor: **CardioFocus** · enrollment: 20 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Endoscopically Guided Ablation

## Key facts

- **NCT ID:** NCT01196923
- **Lead sponsor:** CardioFocus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-03
- **Final completion:** 2012-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01196923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01196923, "Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01196923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*